Thursday, April 7, 2011
Malaria drug slows pancreatic cancer growth in mouse models
Malaria drug slows pancreatic cancer growth in mouse models
Dana-Farber Cancer Institute scientists report that they have shrunk or slowed the growth of notoriously resistant pancreatic tumours in mice, using a drug routinely prescribed for malaria and rheumatoid arthritis.
The pre-clinical results, which will appear in the April issue of the journal Genes & Development and is currently published on its website, have already prompted
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment